Summary. The concentration of biologically active insulin was measured by the isolated fat cell method in serum and urine from healthy subjects and compared with the concentration of immunoreactive insulin. In both urine and serum the values obtained by the two methods correlated closely. In addition, there was a close correlation between the concentration of biologically active and immunoreactive insulin in urine from maturity onset diabetics. Therefore, conclusions on the excretion in the urine and the urinary clearance of insulin, which are based on measurements of immunoreactive insulin, are also valid for biologically active insulin. Key w.ords: Urinary excretion of insulin, insulin-like activity, immunoreactive insulin, isolated fat cells, maturity onset diabetics.
A number of reports have been concerned with the excretion of immunoreactive insulin (IRI) in human urine [1] [2] [3] [4] [5] [6] [7] [8] and it is generally agreed that only a small fraction of the insulin filtered in the glomeruli is excreted in the urine as IRI. The remainder is reabsorbed and degraded [2, 4] . Rubenstein et al. [6] studied 33 healthy subjects and found relatively constant insulin clearances (range 0.23-0.87 ml/min) under conditions where the concentration of insulin in plasma and the urinary flow varied widely. Orskov and Johansen [7] found that the renal clearance for insulin during oral glucose tolerance tests repeated at weekly intervals varied with a factor of less than 1.7. These findings have led to the conclusion that the * Holds a DANIDA Scholarship. Present address: Drug Research & Control Centre, 6, Abou-Hazem St.-Pyramids Ave., Cairo, Egypt. ** To whom inquiries should be addressed. concentration of insulin in the urine is a useful indicator of average serum insulin Values over long periods of time.
Studies on some insulin degrading systems from liver and fat [9, 10] have shown that the rate of loss of the ability of insulin to bind to receptors exceeds the rate of loss of immunoreactivity. Since the receptor binding affinity appears closely correlated to the biological potency [11, 12] it seemed conceivable that the small fraction of the filtered immunoreactive insulin which appears in the urine, was not fully biologically potent. Little is known about insulin in urine assessed with biological techniques (for recent review see [13] ). Liebermann [14] measured the insulin-like activity (ILA) in urine by the rat epididymal fat pad method and found a mean excretion rate of 50 ~tU/min in healthy, fasting subjects. However, ILA measured in this way might to a large extent have represented factors other than insulin. We therefore decided to study insulin in urine from both healthy subjects and maturity onset diabetics in order to answer the question: Is the biological potency retained in the approximately 0.5% of the filtered insulin which appears in the urine as IRI? The ILA was measured by the isolated fat cell method [15, 16] both in the absence (total ILA) and in the presence (non-suppressible ILA) of an excess of insulin antibodies. Preliminary results have been presented elsewhere [17] .
Material and Methods

Subjects
The healthy persons were aged 20-38 years and were within 10% of their ideal body weight. The maturity onset diabetics were of normal weight and aged 45-70 years. They were treated with tolbutamide and diet or with diet alone. 
Methods
Urine was collected in 20 ml precooled vials (-20 ~ C) which contained 20 mg of bovine serum albumin (Sigma, fraction V). Thereby the temperature of the urine decreased immediately to about 10 ~ C. The urine samples were kept frozen at -20 ~ C for up to 4 weeks whereafter they were thawed and dialyzed for 24 h at 4 ~ C against two changes of albumin-free buffer (800 ml) of the same ionic composition as that used for incubation. Visking membrane (10 mm, Union Carbide Comp., New York) was used since it has previously been shown to be the least insulin permeable of several dialysis membranes, i. e. loss of immunoreactive insulin after 48 h averaged 32% [7] .
Serum samples were prepared as previously described [18] and then subjected to dialysis. In addition, a solution of albumin (10 mg/ml of water) was dialyzed together with the urine or serum samples; this was used for preparation of insulin standard solutions.
The biological activity was measured by the isolated fat cell method using the conversion of [3 -3H] glucose to 3H-lipids as the parameter for insulin activity and extraction of the 3H-lipids by the addition of a toluene-based scintillation fluid directly to the incubation vials. The previously published procedure [16, 12] was modified as follows: The incubation medium was buffered with 25.0 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES). The exact composition of the medium is given elsewhere [19] . Each incubation vial contained either urine (final dilution of 1 : 2), serum (final dilution of 1 : 7) or pig insulin standard (NOVO, monocomponent, 28 U/mg) in one of the following concentrations: 100, 15, 10, 6.7, 4.4, 3.0, 2.0, 1.3, or 0 ~tU/ml. Each standard was assayed in 4 replicates and each serum or urine sample was assayed in 8 replicates: 4 in the absence and 4 in the presence of guinea pig antiinsulin serum sufficient to neutralize the effect of 100 ~tU of the standard insulin. When 12SI-labelled insulin was present in the incubation medium, the scintillation fluid was transferred to another counting vial in order to avoid interference with the counting of 3H-activity. The suppressible ILA was calculated as the difference between the total ILA (i. e. in the absence of anti-insulin) and the non-suppressible ILA (i. e. in the presence of anti-insulin). If no significant difference was obtained the suppressible ILA was recorded as zero.
The radioimmunoassay was carried out with a chromatographic wick technique as previously described for serum [20] and urine [7] . The insulin standard solutions were the same as those used in the fat cell assay. The anti-insulin did not discriminate between human insulin and human proinsulin.
Evaluation of Methods
The loss of porcine insulin after the dialysis was measured several times and ranged from 4-24% (mean 13%). In five experiments a trace amount of 1251-labelled insulin (30 Ci/g, final concentration 0.9 /xU/ml) was added to dialyzed urine samples and the specific activity (i. e. 125I-activity per vU) was found to remain constant (97% _+ 3%, SD) after a second dialysis. Finally the recovery of biological activity of insulin added to dialyzed urine was indistinguishable from that of insulin added to buffer (102% _+ 4%, SD, n=5).
It has previously been shown that the concentration of insulin in the urine can be measured accurately with the wick technique [7] . However, it is essential for both assay methods that the urine is cooled immediately and always handled in the cold. Urine samples which had been standing at room temperature for 30-60 min showed sometimes ILA values of more than 100 ~U/ml and there was no effect of anti-insulin, i. e. the insulin concentration could not be measured by the fat cell method. We suspect that these effects are due to contamination with bacteria which produce proteases with insulin-like activity [21, 22] . In such samples 125I-labelled insulin was also degraded, even at 4 ~ C, to an extent which made it impossible to measure the IRI.
Results and Discussion
It has previously been shown that the antibody-suppressible insulin-like activity (suppressible ILA) in native serum from healthy subjects corresponds closely to the immunoreactive insulin (IRI) [18] . The data shown in Figure 1 confirms this finding for dialyzed sera. The concentrations of non-suppressible ILA ranged from the equivalent of 10 to 35 ~tU of insulin per ml and were not correlated with the values of suppressible ILA. Previous results have shown that the dose-response curve of total non-suppressible ILA in serum is not parallel to that of insulin [18] and the estimated potency concentrations of non-suppressible ILA are therefore only valid at the particular serum dilution of i : 7. Figure 2 shows that a close correlation also exists between the suppressible ILA and the IRI in the dialyzed urine samples. It appears that the regression line intercepts with the ordinate at a value of about 2 ~xU/ml. Urine from healthy subjects contains proinsulin in a concentration of about 11% (w/v) of that of insulin [23] and this could be the reason since proinsulin has a potency which is only a few per cent of that of insulin [24] , whereas the anti-insulin used in the radioimmunoassay did not distinguish between insulin and proinsulin. In fact treatment of 7 urine samples with trypsin under conditions at which pro-insulin is converted to des-alanine B-30 insulin [24] caused a slight but significant increase in the suppressible ILA. Constan et al. [23] recently reported similar findings using specific radioimmunoassays to distinguish between insulin and proinsulin. The non-suppressible ILA in the dialyzed urine ranged from 0-8 ~tU/ml (measured value times the dilution factor of 2). In most cases the concentration was 2-3 ~tU/ml). However, as explained in Evaluation of Methods, non-suppressible ILA may appear in urine without representing physiological non-suppressible ILA excreted by the kidneys. The fact that the rate of excretion is low (or possibly unmeasurable with the present technique) is not surprising since it has been reported that most of the non-suppressible ILA in serum has a molecular weight of about 90,000 [25] . Furthermore, a carrier protein (molecular weight about 60,000) has been described for the small molecular weight non-suppressible ILA (NSILA-s) [26] and it is likely that more than 90% of the NSILA-s is present in serum in a bound state [27] . Figure 3 shows that the suppressible ILA and IRI are also closely correlated in urine from maturity onset diabetics. The values of non-suppressible ILA were not different from those found in urine from healthy persons.
The results strongly suggest that the suppressible ILA and IRI in serum and urine are the same entity, i. e. insulin. From this it follows that valid conclusions on the renal handling of insulin can be drawn from studies based on measurement of immunoreactive insulin in serum and urine.
